Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (1) | Back to Search
Impact of use of PDAs on drug regulatory efforts
- In: Pharmacy Information Section - Session Short Oral Presentations on Thursday, 8 September 2005, 9:00-12:00
- At: Cairo (Egypt) (2005)
- Type: Presentations + Posters
- By: SPEED, Arin (Management Sciences for Health, Arlington, United States of America)
- Co-author(s): Ndomondo-Sigonda (TFDA, DAR ES SALAAM, Tanzania)
Kosaras (SATELLIFE, BOSTON, United States of America)
Kraushaar (Management Sciences for Health, ARLINGTON, United States of America)
Risha (Management Sciences for Health, DAR ES SALAAM, Tanzania)
Phumtim (Management Sciences for Health, ARLINGTON, United States of America) - Abstract:
Aims: Collection of correct and timely drug inspection and testing data is critical in drug regulation. Tanzanian Food and Drug Authority (TFDA) field inspectors require ready access to TFDA’s drug marketing authorization database and need to efficiently collect and submit inspection data. Methods: Together with Management Sciences for Health,
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023